![Show Menu](styles/mobile-menu.png)
![Page Background](./../common/page-substrates/page0936.jpg)
COMET Trial: metachronous oligometastases
Palma D, BMC Cancer 2012
Principal Investigators
D. Palma, S. Senan
Target Sample Size
99
Participants
Canada
Netherlands
Scotland
Australia
Primary tumor
controlled
Maximum of 3
lesions in any organ